PD
CRBU icon

Point72 (DIFC)’s Caribou Biosciences CRBU Stock Holding History

Point72 (DIFC)’s Portfolio CRBU Stock Details CRBU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$77 Sell
33
-5,202
-99% -$9.82K ﹤0.01% 1112
2025
Q2 		$6.6K Buy
5,235
+4,580
+699% +$4.5K ﹤0.01% 1356
2025
Q1 		$598 Buy
+655
New +$851 ﹤0.01% 1596
2024
Q4 		– Sell
-3,786
Closed -$7.42K – 1583
2024
Q3 		$7.42K Sell
3,786
-26,371
-87% -$54K ﹤0.01% 1284
2024
Q2 		$49.5K Buy
30,157
+23,995
+389% +$76.7K ﹤0.01% 1092
2024
Q1 		$31.7K Buy
+6,162
New +$38K ﹤0.01% 1257

Other funds holding CRBU

P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Point72 (DIFC)'s CRBU Position: Q3 2025 in Review

Point72 (DIFC) reduced its Caribou Biosciences (CRBU) stake by 99% in Q3 2025, selling an estimated $9.82K and leaving 33 shares worth $77. The position accounts for ﹤0.01% of the portfolio, ranked #1112.

Point72 (DIFC) first reported a position in CRBU in Q1 2024 and has held it in 6 quarters since. The position peaked at $49.5K in Q2 2024. 117 funds tracked by Wall St. Rank hold CRBU as of Q3 2025.

  • Point72 (DIFC) held 33 shares of Caribou Biosciences worth $77 as of Q3 2025.
  • Point72 (DIFC) sold 5,202 Caribou Biosciences shares in Q3 2025, an estimated $9.82K.
  • Caribou Biosciences made up ﹤0.01% of Point72 (DIFC)'s portfolio in Q3 2025, its #1112 holding.
  • Point72 (DIFC) first reported a position in Caribou Biosciences in Q1 2024 and has held it in 6 quarters since.
  • Point72 (DIFC)'s Caribou Biosciences position peaked at $49.5K in Q2 2024.
  • 117 funds tracked by Wall St. Rank held Caribou Biosciences as of Q3 2025.

Based on Point72 (DIFC)'s 13F filing for Q3 2025, filed 14 Nov 2025.